Table 1a.
Non-opioid sedating medications prescribed to a cohort of HIV-infected participants with past year substance dependence or lifetime history of injection drug use (n=250)
| Generic name | Number of participants n (%) |
|---|---|
| Gabapentin | 56 (22%) |
| Mirtazapine | 39 (16%) |
| Trazodone | 36 (14%) |
| Hydroxyzine | 29 (12%) |
| Diphenhydramine | 25 (10%) |
| Amitriptyline | 20 (8%) |
| Doxepin | 20 (8%) |
| Zolpidem | 20 (8%) |
| Quetiapine | 19 (8%) |
| Clonazepam | 18 (7%) |
| Butabarbital | 15 (6%) |
| Prazosin | 14 (6%) |
| Cyclobenzaprine | 13 (5%) |
| Clonidine | 12 (5%) |
| Lorazepam | 10 (4%) |
| Chlorpromazine | 6 (2%) |
| Aripirazole | 5 (2%) |
| Dronabinol | 5 (2%) |
| Nortripyline | 5 (2%) |
| Perphenazine | 5 (2%) |
| Benztropine | 4 (2% |
| Buspirone | 4 (2%) |
| Pregabalin | 4 (2%) |
| Risperidone | 4 (2%) |
| Haloperidol | 3 (1%) |
| Ziprasizone | 3 (1%) |
| Promethazine | 2 (1%) |
| Alprazolam | 2 (1%) |
| Tizanidine | 1 (<1%) |
| Chlordiazepoxide | 1 (<1%) |
| Fluphenazine | 1 (<1%) |
| Methocarbamol | 1 (<1%) |
| Paliperidone | 1 (<1%) |
| Phenobarbital | 1 (<1%) |